Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Transplants - are mice leading the way?

05.07.2004


A new protocol for bone marrow transplants, which does not require the destruction of the recipient’s immune system before transfer of the new bone marrow, is described by a group of Oxford scientists in the 6th of July issue of the Proceedings of the National Academy of Sciences of the United States of America.

Furthermore, Luis Graça, Alain Le Moine, Herman Waldmann and colleagues from the University of Oxford, UK also found that following bone marrow transplant it is possible to successfully transplant other organs from the same donor, including skin, the most difficult organ to be successfully transplanted, into this now hybrid/chimeric bone marrow recipient.

The number of human tissue transplants is on the increase all over the world. In Europe, hundreds of thousands of tissue transplants are performed each year, while only in 1999 as many as 750 000 people in the United States of America received human tissue, twice as many as in 1990.



Graça, Le Moine and Waldmann’s team have been working with mice for a number of years to find alternative protocols for safer and more effective organ transplantations.

Because the immune system has evolved to react against any foreign intruder while remaining non-responsive against its own body, organs from other individuals are seen as foreign and so potentially dangerous which leads to their rapid destruction by the immune system, the body’s defence mechanism. This creates serious problems in clinical transplantation and until now only the use of strong immunosuppressive drugs permits relative transplantation success. This however is not ideal, not only because rejection frequently occurs but also because these drugs compromise the entire immune system making individuals much more susceptible to infection or cancer.

Graça, Le Moine and colleagues work on an alternative model of tolerance based on the use of antibodies against several proteins found in the cells involved in organ rejection. Although the idea of antibodies is not new, these have been mostly used to delete entire populations of cells involved in the graft rejection process. This has the disadvantage of creating “ holes” in the immune system and, like the immunosuppressive therapies widely used in transplant, increase the recipient/host’s disease susceptibility.

What is interesting about the Oxford’s scientists work is that their antibodies do not seem to kill the host cells involved in organ rejection but instead apparently re-programme these cells rendering them tolerant to the foreign organ while leaving the remaining immune system intact and fully operational. It is this specificity of the treatment, the capacity of only making tolerant the cells specific for the foreign organ while keeping the remaining immune system undamaged, that makes Graça, Le Moine and colleagues’ work so exciting.

However, it is still not clear what the mechanism is behind this organ-specific tolerance and this has created problems to the development of human therapies. In the work now published, Graça, Le Moine and colleagues investigate claims that CD4+CD25+ TCR+ cells, a group of cells of the immune system called this way because they express in their cellular membrane the three proteins: CD4, CD25 and TCR, are capable of regulating specific parts of the immune system without affecting the remaining immune cells and might be the cells responsible for inducing the type of organ transplant tolerance observed after Graça and Le Moine’s antibody therapy.

Unfortunately, the results by the team of scientists do not support the hypothesis. Nevertheless, this is still a very important result as it undoubtedly challenges the wide spread assumption that these cells are main regulators of immune responses.

Furthermore, Graça, Le Moine and colleagues also describe a new protocol for bone marrow transplantation and successfully achieve a skin graft transplant between totally different donors and recipients something never achieved before without immune deletion.

In fact, the team of scientists show how a course of their non-depleting antibodies, which are specific for proteins found on the membrane of the cells involved in graft rejection, when given at the same time as a bone marrow transplant, leads to complete acceptance of this foreign bone marrow. This is extraordinarily important as the normal protocol for bone marrow transplants require at least partial destruction of the recipient immune system so the new bone marrow would not be rejected.

Graça, Le Moine and colleagues also show for the first time that skin from a fully foreign donor is also accepted if this organ is transplanted together with bone marrow cells from the same donor while receiving the team’s set of tolerogenic antibodies.

These results are extremely important first because they describe an alternative and much more effective protocol to control the immune system in bone marrow transplants. Secondly, their new protocol of transferring bone marrow together with the organ to transplant proved much more effective, to such a extent that even a totally foreign skin graft was successful, something which has never been accomplished before in the absence of immunosuppression. In a world where more and more transplants are necessary as result of an increasing aging population this is a critical breakthrough.

Finally, Graça, Moine and colleagues capacity of “ re-programme” the immune system without affecting its whole capacity to fight infection might prove extremely important also in other diseases where pathology results from deregulation of the immune system as it seems to be the case in diabetes, rheumatoid arthritis or multiple sclerosis.

Ana Paula Gravito | alfa
Further information:
http://www.oct.mct.pt

More articles from Life Sciences:

nachricht Researchers identify potentially druggable mutant p53 proteins that promote cancer growth
09.12.2016 | Cold Spring Harbor Laboratory

nachricht Plant-based substance boosts eyelash growth
09.12.2016 | Fraunhofer-Institut für Angewandte Polymerforschung IAP

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Electron highway inside crystal

Physicists of the University of Würzburg have made an astonishing discovery in a specific type of topological insulators. The effect is due to the structure of the materials used. The researchers have now published their work in the journal Science.

Topological insulators are currently the hot topic in physics according to the newspaper Neue Zürcher Zeitung. Only a few weeks ago, their importance was...

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Researchers identify potentially druggable mutant p53 proteins that promote cancer growth

09.12.2016 | Life Sciences

Scientists produce a new roadmap for guiding development & conservation in the Amazon

09.12.2016 | Ecology, The Environment and Conservation

Satellites, airport visibility readings shed light on troops' exposure to air pollution

09.12.2016 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>